This Drug Could Be the Next Ozempic. Bootlegs Are Already Selling Online. - Wall Street Journal
George Karavetsos, shareholder in the firm’s FDA & Biotechnology section and leader of the White Collar, Compliance & Investigations practice, was featured in a Wall Street Journal article entitled "This Drug Could Be the Next Ozempic. Bootlegs Are Already Selling Online."
Contributors
Related Services & Industries